Marshall Wace, LLP Tango Therapeutics, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 109,269 shares of TNGX stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,269Holding current value
$1.01 Million% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding TNGX
# of Institutions
126Shares Held
88.8MCall Options Held
2KPut Options Held
1.6K-
Trv Gp Iv, LLC Boston, MA19.2MShares$178 Million73.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$124 Million3.02% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$76 Million3.39% of portfolio
-
Nextech Invest Ag5.53MShares$51.3 Million8.22% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$48.9 Million0.95% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $816M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...